Skip to main content
Log in

Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Schwarz MI, Fontenot AP (2004) Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med 25:133–140

    Article  PubMed  Google Scholar 

  2. Sakai M, Kubota T, Kuwayama Y et al (2011) Diffuse alveolar hemorrhage associated with lenalidomide. Int J Hematol 93:830–831

    Article  PubMed  Google Scholar 

  3. Tsuyuguchi K, Wada M (2011) Management of adverse effect with antituberculousis chemotherapy. Kekkaku 86:87–99

    PubMed  Google Scholar 

  4. Dimopoulos M, Spencer A, Attal M et al (2007) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357:2123–2132

    Article  CAS  PubMed  Google Scholar 

  5. Weber DM, Chen C, Niesvizky R et al (2007) Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 357:2133–2142

    Article  CAS  PubMed  Google Scholar 

  6. Thornburg A, Abonour R, Smith P et al (2007) Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide. Chest 131:1572–1574

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tetsuya Kubota.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakai, M., Kubota, T., Takaoka, M. et al. Successful re-administration of lenalidomide after lenalidomide-induced pulmonary alveolar hemorrhage in a patient with refractory myeloma. Ann Hematol 94, 891–892 (2015). https://doi.org/10.1007/s00277-014-2260-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2260-4

Keywords

Navigation